We are live on ! Find out more
LI

LMCG Investments Portfolio holdings

AUM $1.87B
1-Year Est. Return 50.61%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+50.61%
3 Year Est. Return
+124.92%
5 Year Est. Return
10 Year Est. Return
AUM
$1.63B
AUM Growth
-$33.2M
Cap. Flow
-$38.6M
Cap. Flow %
-2.37%
Top 10 Hldgs %
28.26%
Holding
244
New
21
Increased
36
Reduced
162
Closed
11

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.83M
2
SHEL icon
Shell
SHEL
+$8.46M
3
MNST icon
Monster Beverage
MNST
+$6.85M
4
WMT icon
Walmart Inc
WMT
+$5.42M
5
INTU icon
Intuit
INTU
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 26.05%
2 Financials 14.19%
3 Healthcare 11.63%
4 Industrials 8.66%
5 Consumer Discretionary 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZU icon
76
iShare MSCI Eurozone ETF
EZU
$9.91B
$7.66M 0.47%
162,193
-12,517
-7% -$612K
UNP icon
77
Union Pacific
UNP
$174B
$7.5M 0.46%
32,910
+13,748
+72% +$3.25M
ELV icon
78
Elevance Health
ELV
$85.5B
$7.16M 0.44%
19,401
-597
-3% -$250K
LULU icon
79
lululemon athletica
LULU
$14.6B
$7.07M 0.43%
18,500
-713
-4% -$233K
CSCO icon
80
Cisco
CSCO
$479B
$6.76M 0.41%
114,152
-4,724
-4% -$270K
NEM icon
81
Newmont
NEM
$119B
$6.68M 0.41%
179,549
-22,963
-11% -$1.05M
AES icon
82
AES
AES
$10.5B
$6.68M 0.41%
518,975
-131,534
-20% -$1.96M
MCHP icon
83
Microchip Technology
MCHP
$46B
$6.48M 0.4%
113,016
-13,243
-10% -$910K
ROL icon
84
Rollins
ROL
$18.2B
$6.37M 0.39%
137,540
-4,477
-3% -$219K
EWJ icon
85
iShares MSCI Japan ETF
EWJ
$23B
$6.37M 0.39%
95,000
-2,202
-2% -$152K
ZBH icon
86
Zimmer Biomet
ZBH
$18.4B
$5.91M 0.36%
55,949
+9,484
+20% +$1.02M
ABNB icon
87
Airbnb
ABNB
$107B
$5.69M 0.35%
43,292
-1,243
-3% -$167K
SLB icon
88
SLB Ltd
SLB
$75B
$5.69M 0.35%
148,295
-73,682
-33% -$3.09M
CNM icon
89
Core & Main
CNM
$8.71B
$5.66M 0.35%
111,115
-135
-0.1% -$6.36K
JAZZ icon
90
Jazz Pharmaceuticals
JAZZ
$16.7B
$5.6M 0.34%
+45,463
New +$5.36M
RRC icon
91
Range Resources
RRC
$8.95B
$5.37M 0.33%
149,365
-3,233
-2% -$107K
QQQ icon
92
Invesco QQQ Trust
QQQ
$484B
$5.27M 0.32%
10,301
-672
-6% -$340K
BKR icon
93
Baker Hughes
BKR
$61.1B
$5.02M 0.31%
122,392
-6,899
-5% -$278K
WDAY icon
94
Workday
WDAY
$44.4B
$4.99M 0.31%
19,325
-203
-1% -$51.9K
INSP icon
95
Inspire Medical Systems
INSP
$1.74B
$4.98M 0.31%
26,868
-3,741
-12% -$726K
EEM icon
96
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$4.71M 0.29%
112,525
-42,826
-28% -$1.9M
WCC
97
WESCO International
WCC
$17.7B
$4.47M 0.27%
+24,681
New +$4.67M
CI icon
98
Cigna
CI
$74.6B
$4.45M 0.27%
16,125
-3,920
-20% -$1.25M
ILF icon
99
iShares Latin America 40 ETF
ILF
$3.76B
$4.36M 0.27%
208,690
-114,890
-36% -$2.76M
EPP icon
100
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
$4.27M 0.26%
97,500
-2,352
-2% -$110K

Similar funds

LMCG Investments's Q4 2024 Portfolio in Review

As of Q4 2024, LMCG Investments held 244 positions worth $1.63B, down 2% from $1.66B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

LMCG Investments's Q4 2024 filing shows 21 new, 36 increased, 162 reduced and 11 closed positions. Its largest new stake was Lam Research: 118,400 shares worth $8.55M. The largest sale was Johnson & Johnson, an estimated $9.83M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • LMCG Investments's largest Q4 2024 buy was Lam Research: 118,400 shares worth $8.55M.
  • LMCG Investments added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $17.9M increase.
  • LMCG Investments's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $9.83M.
  • LMCG Investments fully exited Alexandria Real Estate Equities in Q4 2024, selling an estimated $1.11M.
  • LMCG Investments's ten largest holdings make up 28% of its $1.63B portfolio in Q4 2024.
  • LMCG Investments opened 21 new positions and closed 11 in Q4 2024.
  • LMCG Investments's portfolio value fell 2% quarter-over-quarter to $1.63B.

Based on LMCG Investments's 13F filing for Q4 2024, filed 16 Jan 2025.